Company profile

PATHWORK DIAGNOSTICS

PATHWORK DIAGNOSTICS has 1 AI-enabled medical device on the FDA list. The first decision was on June 8, 2010 and the most recent on June 8, 2010 (PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPE). Its most common review panel is Clinical Toxcicology (1 device).

1AI devices

2010First decision

2010Latest decision

1Specialties

Timeline

June 8, 2010 · 510(k) K092967PATHWORK TISSUE OF ORIGIN TEST KIT-FFPE (ORIGIN TEST KIT-FFPE · Clinical Toxcicology · OIW